AVTX
Avalo Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD18.82
+0.61 (+3.35%)
Rating:C+
Company Profile
CEO
Garry A. Neil
IPO Date
2015-10-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$18.52
Prev. Close
$18.21
Day Low
$18.09
Day High
$19.00
52W Low
$6.21
52W High
$24.27
Market Cap
$0.21B
Volume
1.08M